AwesomeCapital
Search This Blog
Friday, July 12, 2019
Fate Therapeutics started at Outperform by Oppenheimer
Target $27
https://www.benzinga.com/stock/FATE/ratings
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.